Screening for those who have had chest radiotherapy before age 30
Since today there are no tools that allow you to predict which lesion will become invasive cancer and which will remain silent for years , for a woman who undergoes screening there is the risk of receiving the diagnosis (and then the diagnostic investigations and treatment) for a lesion that probably would never have developed into an invasive tumor. However, the research carried out to date suggests that this risk is lower than the benefits obtained by carrying out the screening with the frequency and in the recommended age groups sedation MRI in Hackettstown, NJ.
Why did my doctor give me a different indication?
Sometimes doctors may suggest more frequent or closer checks for risk factors, for example several other cases of breast or ovarian cancer in the family , which increase the likelihood of breast cancer developing even at a young age. .
Other experts consider that a greater number of checks could allow to find a greater number of nodules: it is important to remember, however, that early diagnosis and therapy are valuable only if they manage to reduce mortality from the disease, otherwise the woman will have suffered the effects. collateral treatment without actually benefiting from it. In the current state of knowledge, scientific evidence guarantees this favorable relationship between risks and benefits only with the methods and frequency indicated in the paragraph “Who should do it and when”.
Women between the ages of 10 and 30 who have undergone chest radiation therapy to treat cancer have a higher risk of developing breast cancer precisely because of the radiation. A specific screening program is also envisaged for them starting from the age of 25 or at least 8 years after radiotherapy: it involves an MRI with contrast medium to be performed every year, associated with bilateral mammography or tomosynthesis with 2D reconstructions.
Screening aims to reduce mortality and increase survival through early diagnosis.
Mammography screening means the execution of mammography that a facility actively offers to a well-identified target population at risk of disease and asymptomatic for the purpose of early diagnosis; screening is not diagnosis. The goal of screening is to reduce mortality.